An examination of Bayesian statistical approaches to modeling change in cognitive decline in an Alzheimer's disease population

Mathematics and Computers in Simulation

Volumn 80, Issue 3, 2009, Pages 561-571

  Bartolucci, Al ^a   Bae, Sejong ^b   Singh, Karan ^b   Griffith, H Randall ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Alzheimer's disease; Bayesian; Change point; Mini mental state; Trajectory

Indexed keywords

ALZHEIMER'S DISEASE; BAYESIAN; BAYESIAN APPROACHES; BAYESIAN STATISTICAL APPROACH; BEFORE AND AFTER; CHANGE-POINTS; COGNITIVE DECLINE; CREDIBLE REGIONS; LINEAR MODEL; MENTAL STATE; MINI-MENTAL STATE EXAMINATIONS; NON-INFORMATIVE PRIOR; POSTERIOR ANALYSIS; REGIONS OF INTEREST;

POPULATION STATISTICS; TRAJECTORIES;

BAYESIAN NETWORKS;

EID: 70449701466     PISSN: 03784754     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matcom.2009.09.002     Document Type: Article

References (28)

1. A.J. Ashby, R.V. Leon, J. Thyagarajan, Bayesian modeling of accelerated life tests with random effects, Technical Report, Department of Statistics, University of Tennessee, Knoxville, 2003.
2. Birch R., and Bartolucci A.A. Determination of the hyperparameters of a prior probability model in survival analysis. Comput. Programs Biomed. 17 (1983) 89-94
3. Carlin B.P., Gelfand A.E., and Smith A.F.M. Hierarchical Bayesian analysis of changepoint problems. Appl. Stat. 41 2 (1992) 389-405
4. Carter R.L., and Blight B.J.N. A Bayesian change-point problem with application to the prediction and detection of ovulation in women. Biometrics 47 4 (1981) 743-751
5. Crum R.M., Anthony J.C., Bassett S.S., and Folstein M.F. Population based norms for the mini-mental state examination by age and educational level. JAMA 269 21 (1993) 2386-2391
6. Dentino A.N., Pieper C.F., Rao M.K., Currie M.S., Harris T., Blazer D.G., and Cohen H.J. Association of interleukin 6 and other biologic variables with depression in older in older people living in the community. J. Am. Geriatr. Soc. 47 (1999) 6-11
7. Dufouil C., Brayne C., and Clayton D. Analysis of longitudinal studies with death and drop out: a case study. Stat. Med. 23 14 (2004) 2215-2226
8. Elliott M.R., and Slope J.T. Use of a Bayesian changepoint model to estimate effects of a graduated driver's licensing program. J. Data Sci. 1 (2003) 43-63
9. Folstein M.F., Folstein S.E., and McHugh P.R. Mini-mental status. A practical method for grading the cognitive status of patients for the clinician. J. Psychiatric Res. 12 3 (1975) 189-198
10. Garre F.G., Zwinderman A.H., Geskus R.B., and Sijpkens Y.W.J. A joint latent class changepoint model to improve the prediction of time to graft failure. J. R. Stat. Soc. A 171 (2008) 299-308
11. Gelfand A.E., and Smith A.F.M. Sampling based approaches to calculating marginal densities. J. Am. Stat. Assoc. 85 (1990) 398-409
12. Gelman A., Carlin J.B., Stern H.S., and Rubin D.B. Bayesian Data Analysis (2004), Chapman and Hall/CRC
13. Hinkley D.V. Inference about the intersection in two phase-regression. Biometrika 56 (1969) 495-504
14. Hinkley D.V., and Schechtman E. Conditional bootstrap methods in the mean shift model. Biometrika 74 (1987) 85-93
15. Holmes C., Ballard C., Lehmann D., Smith A.D., Beaumont H., Day I.N., Khan M.N., Lovestone S., McCulley M., Morris C.M., Munoz D.G., Obrien K., Russ C., Ser T.D., and Warden D. Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation. J. Neurol. Neurosurg. Psychiatry 76 (2005) 640-643
16. Holmes C., Cairns N., Lantos P., and Mann A. The validity of current research diagnostic criteria for Alzheimer's disease vascular dementia and dementia with Lewy bodies. Br. J. Psychiatry 174 (1999) 45-50
17. Hughes C.R., Berg L., Danziger W.L., Cohen L.A., and Martin R.L. A new clinical scale for the staging of dementia. Br. J. Psychiatry 140 (1982) 566-572
18. Kuskowski M.A., Mortimer J.A., Morley G.K., Malone S.M., and Okaya A.J. Rate of cognitive decline in Alzheimer's disease is associated with EEG alpha power. Biol. Psychiatry 33 8-9 (1993) 650-652
19. Lin J. A two stage failure model for Bayesian change point analysis. IEEE Trans. Reliab. 57 2 (2008) 388-393
20. Lin H., Turnbull B.W., McCulloch C.E., and Slate E.H. Latent class models for joint analysis of longitudinal biomarker and event process data: application to longitudinal prostate-specific antigen readings and prostate cancer. J. Am. Stat. Assoc. 97 (2002) 53-65
21. McKhann G., Drachman D., Folstein M., Katxman R., Price D., and Stadlan E. Clinical diagnosis for Alzheimer's disease. Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task force on Alzheimer's disease. Neurology 34 (1984) 939-944
22. Pauler D.K., and Finkelstein D.M. Predicting time to prostate cancer recurrence based on joint models for non-linear longitudinal biomarkers and event time outcomes. Stat. Med. 21 (2002) 3897-3911
23. Pauler D.K., and Laird N.M. A mixture model for longitudinal data with application to assessment of noncompliance. Biometrics 56 (2000) 464-472
24. Perry E., McKeith I., and Ballard C. The K variant of the butyrylcholinesterase enzyme is associated with significantly slower cognitive decline and predicts treatment response in dementia patients. Neurology 10 (2003) 1852-1853
25. Raji M.A., Reyes-Ortiz C.A., Kuo Y.F., Markides K.S., and Ottenbacher K.J. Depressive symptoms and cognitive change in older Mexican Americans. J. Geriatr. Psychiatry Neurol. 20 145 (2007) 145-152
26. Raudenbusch S.W., Johnson C., and Simpson R.J. A multivariate, multilevel Rausch model for self reported criminal behavior. Sociol. Methodol. 33 1 (2003) 169-211
27. Spiegelhalter D., Thomas A., Best N., and Lunn D. WinBUGS Version 1.4 User Manual (2003), Cambridge
28. Tombaugh T.N. Test-retest reliable coefficients and 5 year change scores for the MMSE and 3MS. Arch. Clin. Neuropsychol. 20 4 (2005) 485-503